The investigational endoscopic procedure may help patients maintain weight loss or lose more weight 3 months after GLP-1 receptor agonist therapy discontinuation.

Olympus ( ($JP:7733) ) has issued an update. Olympus Corporation has announced a new corporate strategy aimed at enhancing its position as a ...

Olympus will cut 2,000 jobs globally in a new corporate strategy to save $150M and invest in AI-driven endoscopy solutions.

After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique technology.

Dinesh Madhok, MD, gastroenterologist CEO of Jacksonville, Fla.-based Borland Groover, joined Becker’s to discuss the three biggest challenges facing gastroenterology practices today. Dr. Madhok was ...

In a region where residents are already squeezed by an affordability crisis, skyrocketing vet bills can feel like the straw ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...

Anesthesia departments are being challenged to deliver the same level of safety and excellence with dwindling resources as hospitals face mounting financial strain. Across the country, anesthesia ...

Thousands of people across Norfolk have been hit by delays getting results of crucial tissue sample tests for diseases such as cancer.

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...

Cutting-edge treatment is available at WVU Medicine for patients facing complex medical diagnoses, including those suffering from gastrointestinal (GI) issues or recovering from some cancer surgeries.